Literature DB >> 19577573

Structural insights into antibody recognition of mycobacterial polysaccharides.

Tomohiko Murase1, Ruixiang Blake Zheng, Maju Joe, Yu Bai, Sandra L Marcus, Todd L Lowary, Kenneth K S Ng.   

Abstract

Mycobacteria are major human pathogens responsible for such serious and widespread diseases as tuberculosis and leprosy. Among the evolutionary adaptations essential for pathogenicity in mycobacteria is a complex carbohydrate-rich cell-wall structure that contains as a major immunomodulatory molecule the polysaccharide lipoarabinomannan (LAM). We report here crystal structures of three fragments from the non-reducing termini of LAM in complex with a murine antibody Fab fragment (CS-35Fab). These structures reveal for the first time the three-dimensional structures of key components of LAM and the molecular basis of LAM recognition at between 1.8- and 2.0-A resolution. The antigen-binding site of CS-35Fab forms three binding pockets that show a high degree of complementarity to the reducing end, the branch point and one of the non-reducing ends of the Y-shaped hexasaccharide moiety found at most of the non-reducing termini of LAM. Structures of CS-35Fab bound to two additional tetrasaccharides confirm the general mode of binding seen in the hexasaccharide and indicate how different parts of LAM are recognized. Altogether, these structures provide a rational basis for understanding the overall architecture of LAM and identify the key elements of an epitope that may be exploited for the development of novel and more effective anti-mycobacterial vaccines. Moreover, this study represents the first high-resolution X-ray crystallographic investigation of oligofuranoside-protein recognition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577573     DOI: 10.1016/j.jmb.2009.06.074

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

1.  Groove-type recognition of chlamydiaceae-specific lipopolysaccharide antigen by a family of antibodies possessing an unusual variable heavy chain N-linked glycan.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Radka Saldova; Mohankumar Muniyappa; Lore Brade; Pauline M Rudd; David J Harvey; Paul Kosma; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2014-03-28       Impact factor: 5.157

2.  Comparative Structural Study of Terminal Ends of Lipoarabinomannan from Mice Infected Lung Tissues and Urine of a Tuberculosis Positive Patient.

Authors:  Prithwiraj De; Libin Shi; Claudia Boot; Diane Ordway; Michael McNeil; Delphi Chatterjee
Journal:  ACS Infect Dis       Date:  2019-12-12       Impact factor: 5.084

3.  Capsular glycan recognition provides antibody-mediated immunity against tuberculosis.

Authors:  Tingting Chen; Caroline Blanc; Yanyan Liu; Elise Ishida; Sarah Singer; Jiayong Xu; Maju Joe; Elizabeth R Jenny-Avital; John Chan; Todd L Lowary; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

4.  Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-N-acetylglucosamine.

Authors:  Caroline Soliman; Anna K Walduck; Elizabeth Yuriev; Jack S Richards; Colette Cywes-Bentley; Gerald B Pier; Paul A Ramsland
Journal:  J Biol Chem       Date:  2018-02-15       Impact factor: 5.157

5.  Specificity of furanoside-protein recognition through antibody engineering and molecular modeling.

Authors:  Parnian Lak; Spandana Makeneni; Robert J Woods; Todd L Lowary
Journal:  Chemistry       Date:  2014-11-20       Impact factor: 5.236

6.  Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria.

Authors:  Robin Wood; Kimberly Racow; Linda-Gail Bekker; Keren Middelkoop; Monica Vogt; Barry N Kreiswirth; Stephen D Lawn
Journal:  BMC Infect Dis       Date:  2012-02-27       Impact factor: 3.090

7.  A bispecific antibody based assay shows potential for detecting tuberculosis in resource constrained laboratory settings.

Authors:  Susmita Sarkar; Xinli L Tang; Dipankar Das; John S Spencer; Todd L Lowary; Mavanur R Suresh
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 8.  Strategies and Tactics for the Development of Selective Glycan-Binding Proteins.

Authors:  Elizabeth M Ward; Megan E Kizer; Barbara Imperiali
Journal:  ACS Chem Biol       Date:  2021-01-26       Impact factor: 4.634

9.  Structure of the trehalose-6-phosphate phosphatase from Brugia malayi reveals key design principles for anthelmintic drugs.

Authors:  Jeremiah D Farelli; Brendan D Galvin; Zhiru Li; Chunliang Liu; Miyuki Aono; Megan Garland; Olivia E Hallett; Thomas B Causey; Alana Ali-Reynolds; Daniel J Saltzberg; Clotilde K S Carlow; Debra Dunaway-Mariano; Karen N Allen
Journal:  PLoS Pathog       Date:  2014-07-03       Impact factor: 6.823

10.  Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.

Authors:  Tingting Chen; Caroline Blanc; Anke Z Eder; Rafael Prados-Rosales; Ana Camila Oliveira Souza; Ryung S Kim; Aharona Glatman-Freedman; Maju Joe; Yu Bai; Todd L Lowary; Rachel Tanner; Michael J Brennan; Helen A Fletcher; Helen McShane; Arturo Casadevall; Jacqueline M Achkar
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.